John Partridge Discusses Whistleblowing and Shifting Corporate Enforcement Priorities with Agenda

In the Media  |  May 16, 2025

Agenda

Partner and Co-Chair of our FDA and Health Care Practice Group, John Partridge, recently spoke to the Financial Times’ Agenda (subscription required) about the importance of maintaining strong internal reporting programs — even as corporate enforcement priorities shift.

John noted that, from the perspective of public companies, the variation in whistleblower programs across jurisdictions makes it “all the more important to have a well-resourced internal reporting and investigation function.”

“This will help public companies to identify and remediate misconduct before it metastasizes to the point of driving someone to report to a whistleblower program.”